Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer

Abstract Background Bromodomain-containing protein (BRD) play a pivotal role in the development and progression of malignant tumours. This study aims to identify prognostic genes linked to BRD-related genes (BRDRGs) in patients with triple-negative breast cancer (TNBC) and to construct a novel progn...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Chen, Yushuai Yu, Chenxi Wang, Zirong Jiang, Xiewei Huang, Yidan Lin, Hongjing Han, Qing Wang, Hui Zhang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-025-03648-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594433214775296
author Wei Chen
Yushuai Yu
Chenxi Wang
Zirong Jiang
Xiewei Huang
Yidan Lin
Hongjing Han
Qing Wang
Hui Zhang
author_facet Wei Chen
Yushuai Yu
Chenxi Wang
Zirong Jiang
Xiewei Huang
Yidan Lin
Hongjing Han
Qing Wang
Hui Zhang
author_sort Wei Chen
collection DOAJ
description Abstract Background Bromodomain-containing protein (BRD) play a pivotal role in the development and progression of malignant tumours. This study aims to identify prognostic genes linked to BRD-related genes (BRDRGs) in patients with triple-negative breast cancer (TNBC) and to construct a novel prognostic model. Methods Data from TCGA-TNBC, GSE135565, and GSE161529 were retrieved from public databases. GSE161529 was used to identify key cell types. The BRDRGs score in TCGA-TNBC was calculated using single-sample Gene Set Enrichment Analysis (ssGSEA). Differential expression analysis was performed to identify differentially expressed genes (DEGs): DEGs1 in key cells, DEGs2 between tumours and controls and DEGs3 in high and low BRDRGs score subgroups in TCGA-TNBC. Differentially expressed BRDRGs (DE-BRDRGs) were determined by overlapping DEGs1, DEGs2 and DEGs3. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and protein-protein interaction (PPI) network analysis were conducted to investigate active pathways and molecular interactions. Prognostic genes were selected through univariate Cox regression and least absolute shrinkage and selection operator (LASSO) regression analyses to construct a risk model and calculate risk scores. TNBC samples from TCGA-TNBC were classified into high and low-risk groups based on the median risk score. Additionally, correlations with clinical characteristics, Gene Set Enrichment Analysis (GSEA), immune analysis, and pseudotime analysis were performed. Results A total of 120 DE-BRDRGs were identified by overlapping 605 DEGs1 from four key cell types, 10,776 DEGs2, and 4,497 DEGs3. GO analysis revealed enriched terms such as ‘apoptotic process,’ ‘immune response,’ and ‘regulation of the cell cycle,’ while 56 KEGG pathways, including the ‘MAPK signaling pathway,’ were associated with DE-BRDRGs. A risk model comprising six prognostic genes (KRT6A, PGF, ABCA1, EDNRB, CTSD and GJA4) was constructed. A nomogram based on independent prognostic factors was also developed. Immune cell abundance was significantly higher in high-risk group. In both risk groups, TP53 exhibited the highest mutation frequency. The expression of KRT6A, ABCA1, EDNRB, and CTSD went decreased progressively in pseudotime. Conclusion A novel prognostic model for TNBC associated with BRDRGs was developed and validated, providing fresh insights into the relationship between BRD and TNBC.
format Article
id doaj-art-b59ed19209fd4af9835698b4ba3fe76b
institution Kabale University
issn 1475-2867
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj-art-b59ed19209fd4af9835698b4ba3fe76b2025-01-19T12:39:34ZengBMCCancer Cell International1475-28672025-01-0125112110.1186/s12935-025-03648-7Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancerWei Chen0Yushuai Yu1Chenxi Wang2Zirong Jiang3Xiewei Huang4Yidan Lin5Hongjing Han6Qing Wang7Hui Zhang8Department of Breast Surgery, Fujian Provincial Hospital, Shengli Clinical Medical College of Fuiian Medical University, Fuzhou University Affiliated Provincial HospitalFujian Medical UniversityThird Department of Breast Surgery, The Third Affiliated Hospital of Kunming Medical University&Yunnan Cancer HospitalDepartment of Breast and Thyroid Surgery, Ningde Clinical Medical College of Fujian Medical University, Ningde Municipal Hospital of Ningde Normal UniversityFujian Medical UniversityFujian Medical UniversitySection 2 of General Surgery Department, The Second People’s Hospital of JingdezhenFujian Medical UniversityDepartment of Breast Surgery, Fujian Provincial Hospital, Shengli Clinical Medical College of Fuiian Medical University, Fuzhou University Affiliated Provincial HospitalAbstract Background Bromodomain-containing protein (BRD) play a pivotal role in the development and progression of malignant tumours. This study aims to identify prognostic genes linked to BRD-related genes (BRDRGs) in patients with triple-negative breast cancer (TNBC) and to construct a novel prognostic model. Methods Data from TCGA-TNBC, GSE135565, and GSE161529 were retrieved from public databases. GSE161529 was used to identify key cell types. The BRDRGs score in TCGA-TNBC was calculated using single-sample Gene Set Enrichment Analysis (ssGSEA). Differential expression analysis was performed to identify differentially expressed genes (DEGs): DEGs1 in key cells, DEGs2 between tumours and controls and DEGs3 in high and low BRDRGs score subgroups in TCGA-TNBC. Differentially expressed BRDRGs (DE-BRDRGs) were determined by overlapping DEGs1, DEGs2 and DEGs3. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and protein-protein interaction (PPI) network analysis were conducted to investigate active pathways and molecular interactions. Prognostic genes were selected through univariate Cox regression and least absolute shrinkage and selection operator (LASSO) regression analyses to construct a risk model and calculate risk scores. TNBC samples from TCGA-TNBC were classified into high and low-risk groups based on the median risk score. Additionally, correlations with clinical characteristics, Gene Set Enrichment Analysis (GSEA), immune analysis, and pseudotime analysis were performed. Results A total of 120 DE-BRDRGs were identified by overlapping 605 DEGs1 from four key cell types, 10,776 DEGs2, and 4,497 DEGs3. GO analysis revealed enriched terms such as ‘apoptotic process,’ ‘immune response,’ and ‘regulation of the cell cycle,’ while 56 KEGG pathways, including the ‘MAPK signaling pathway,’ were associated with DE-BRDRGs. A risk model comprising six prognostic genes (KRT6A, PGF, ABCA1, EDNRB, CTSD and GJA4) was constructed. A nomogram based on independent prognostic factors was also developed. Immune cell abundance was significantly higher in high-risk group. In both risk groups, TP53 exhibited the highest mutation frequency. The expression of KRT6A, ABCA1, EDNRB, and CTSD went decreased progressively in pseudotime. Conclusion A novel prognostic model for TNBC associated with BRDRGs was developed and validated, providing fresh insights into the relationship between BRD and TNBC.https://doi.org/10.1186/s12935-025-03648-7Triple-negative breast cancerBromodomain-containing proteinImmune microenvironmentPrognosis
spellingShingle Wei Chen
Yushuai Yu
Chenxi Wang
Zirong Jiang
Xiewei Huang
Yidan Lin
Hongjing Han
Qing Wang
Hui Zhang
Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
Cancer Cell International
Triple-negative breast cancer
Bromodomain-containing protein
Immune microenvironment
Prognosis
title Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
title_full Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
title_fullStr Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
title_full_unstemmed Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
title_short Construction of the bromodomain-containing protein-associated prognostic model in triple-negative breast cancer
title_sort construction of the bromodomain containing protein associated prognostic model in triple negative breast cancer
topic Triple-negative breast cancer
Bromodomain-containing protein
Immune microenvironment
Prognosis
url https://doi.org/10.1186/s12935-025-03648-7
work_keys_str_mv AT weichen constructionofthebromodomaincontainingproteinassociatedprognosticmodelintriplenegativebreastcancer
AT yushuaiyu constructionofthebromodomaincontainingproteinassociatedprognosticmodelintriplenegativebreastcancer
AT chenxiwang constructionofthebromodomaincontainingproteinassociatedprognosticmodelintriplenegativebreastcancer
AT zirongjiang constructionofthebromodomaincontainingproteinassociatedprognosticmodelintriplenegativebreastcancer
AT xieweihuang constructionofthebromodomaincontainingproteinassociatedprognosticmodelintriplenegativebreastcancer
AT yidanlin constructionofthebromodomaincontainingproteinassociatedprognosticmodelintriplenegativebreastcancer
AT hongjinghan constructionofthebromodomaincontainingproteinassociatedprognosticmodelintriplenegativebreastcancer
AT qingwang constructionofthebromodomaincontainingproteinassociatedprognosticmodelintriplenegativebreastcancer
AT huizhang constructionofthebromodomaincontainingproteinassociatedprognosticmodelintriplenegativebreastcancer